Bioelectrical impedance methods in clinical research: a follow-up to the NIH Technology Assessment Conference.
In 1994, the National Institutes of Health (NIH) convened a Technology Assessment Conference "to provide physicians with a responsible assessment of bioelectrical impedance analysis (BIA) technology for body composition measurement." In 1997, Serono Symposia USA, Inc., organized an invited panel of scientists and clinicians, with extensive research and clinical experience with BIA, to provide an update. Panel members presented reviews based on their own work and published studies for the intervening years. Updates were provided on the single and multifrequency BIA methods and models; continued clinical research experiences; efforts toward establishing population reference norms; and the feasibility of establishing guidelines for potential diagnostic use of BIA in a clinical setting. This report provides a summary of the panel's findings including a consensus on several technical and clinical issues related to the research use of BIA, and those areas that are still in need of additional study.
Ellis
K J
KJ
Department of Pediatrics, USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Texas Children's Hospital, Houston 77030-2600, USA. kellis@bcm.tmc.edu
Bell
S J
SJ
Chertow
G M
GM
Chumlea
W C
WC
Knox
T A
TA
Kotler
D P
DP
Lukaski
H C
HC
Schoeller
D A
DA
D001823:Body Composition; D017097:Electric Impedance; D006801:Humans; D009316:National Institutes of Health (U.S.); D012016:Reference Values; D012106:Research; D013673:Technology Assessment, Biomedical; D014481:United States